Krishnan Ramaswamy

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Cross Sectional

Radical Prostatectomy

Prostate Cancer

Top Venues

Prostate cancer and prostatic diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Stephen J Freedland, Wei Gao, Angela Lax, Hongbo Yang, Krishnan Ramaswamy, David Russell, Agnes Hong, Jasmina I Ivanova
Real-world outcomes following biochemical recurrence after definitive therapy with a short prostate-specific antigen doubling time: potential role of early secondary treatment. Prostate cancer and prostatic diseases (2024)
Daniel J George, Archana M Agarwal, Krishnan Ramaswamy, Zachary Klaassen, Rhonda L Bitting, David Russell, Rickard Sandin, Birol Emir, Hongbo Yang, Wei Song, Yilu Lin, Agnes Hong, Wei Gao, Stephen J Freedland
Emerging racial disparities among Medicare beneficiaries and Veterans with metastatic castration-sensitive prostate cancer. Prostate cancer and prostatic diseases (2024)
Daniel J George, Krishnan Ramaswamy, Hongbo Yang, Qing Liu, Adina Zhang, Alexandra Greatsinger, Jasmina I Ivanova, Betty Thompson, Birol Emir, Agnes Hong, Stephen J Freedland
Real-world overall survival with abiraterone acetate versus enzalutamide in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer. Prostate cancer and prostatic diseases (2024)
Stephen J Freedland, Agnes Hong, Nader El-Chaar, Sharanya Murty, Krishnan Ramaswamy, Anna D Coutinho, David Nimke, Alicia K Morgans
Prostate-specific antigen response and clinical progression-free survival in Black and White men with chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamide in a real-world setting. Prostate cancer and prostatic diseases (2022)
Bertrand F Tombal, Stephen J Freedland, Andrew J Armstrong, Tomasz M Beer, Arnulf Stenzl, Cora N Sternberg, Maha H A Hussain, Arijit Ganguli, Krishnan Ramaswamy, Hemant Bhadauria, Cristina Ivanescu, James Turnbull, Stefan Holmstrom, Fred Saad
Impact of enzalutamide on patient-reported fatigue in patients with prostate cancer: data from the pivotal clinical trials. Prostate cancer and prostatic diseases (2021)
Scott T Tagawa, Krishnan Ramaswamy, Ahong Huang, Jack Mardekian, Neil M Schultz, Li Wang, Rickard Sandin, Stanislav Lechpammer, Daniel J George
Survival outcomes in patients with chemotherapy-naive metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone acetate. Prostate cancer and prostatic diseases 24 (4) (2021)
Daniel J George, Krishnan Ramaswamy, Ahong Huang, David Russell, Jack Mardekian, Neil M Schultz, Nora Janjan, Stephen J Freedland
Survival by race in men with chemotherapy-naive enzalutamide- or abiraterone-treated metastatic castration-resistant prostate cancer. Prostate cancer and prostatic diseases (2021)